Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Neutral tumor evolution?

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: M(f) ~ 1/f is an uninformative test for identifying (non-)neutrality in simulated and real data.

Data availability

This study used data generated by the The Cancer Genome Atlas (TCGA, a collection of publicly available data from human tissues; We ran dN/dS analyses on the data from TCGA, using published CaVeMan19,20 single-nucleotide variant calls, and ASCAT21 copy number calls, as described in Martincorena et al.13. Simulation data can be reproduced by using the R and Java scripts provided.


  1. 1.

    Greaves, M. & Maley, C. C. Nature 481, 306–313 (2012).

    CAS  Article  Google Scholar 

  2. 2.

    Yates, L. R. & Campbell, P. J. Nat. Rev. Genet. 13, 795–806 (2012).

    CAS  Article  Google Scholar 

  3. 3.

    Andor, N. et al. Nat. Med. 22, 105–113 (2016).

    CAS  Article  Google Scholar 

  4. 4.

    Nowell, P. C. Science 194, 23–28 (1976).

    CAS  Article  Google Scholar 

  5. 5.

    Nik-Zainal, S. et al. Cell 149, 994–1007 (2012).

    CAS  Article  Google Scholar 

  6. 6.

    Dentro, S. C., Wedge, D. C. & Van Loo, P. Cold Spring Harb. Perspect. Med. 7, a026625 (2017).

    Article  Google Scholar 

  7. 7.

    Williams, M. J., Werner, B., Barnes, C. P., Graham, T. A. & Sottoriva, A. Nat. Genet. 48, 238–244 (2016).

    CAS  Article  Google Scholar 

  8. 8.

    Johnson, D. C. et al. Blood 130, 1639–1643 (2017).

    CAS  Article  Google Scholar 

  9. 9.

    Zack, T. I. et al. Nat. Genet. 45, 1134–1140 (2013).

    CAS  Article  Google Scholar 

  10. 10.

    Bozic, I., Gerold, J. M. & Nowak, M. A. PLoS Comput. Biol. 12, e1004731 (2016).

    Article  Google Scholar 

  11. 11.

    Nei, M. & Gojobori, T. Mol. Biol. Evol. 3, 418–426 (1986).

    CAS  PubMed  Google Scholar 

  12. 12.

    Goldman, N. & Yang, Z. Mol. Biol. Evol. 11, 725–736 (1994).

    CAS  PubMed  Google Scholar 

  13. 13.

    Martincorena, I. et al. Cell 171, 1029–1041.e21 (2017).

    CAS  Article  Google Scholar 

  14. 14.

    Forbes, S. A. et al. Nucleic Acids Res. 45, D777–D783 (2017).

    CAS  Article  Google Scholar 

  15. 15.

    Williams, M. J. et al. Nat. Genet. 50, 895–903 (2018).

    CAS  Article  Google Scholar 

  16. 16.

    Al Hammal, O., Alonso, D., Etienne, R. S. & Cornell, S. J. PLoS Comput. Biol. 11, e1004134 (2015).

    Article  Google Scholar 

  17. 17.

    Herzog, H. A., Bentley, R. A. & Hahn, M. W. Proc. R. Soc. Lond. B 271, S353–S356 (2004).

    Article  Google Scholar 

  18. 18.

    Leigh, E. G. Jr. J. Evol. Biol. 20, 2075–2091 (2007).

    Article  Google Scholar 

  19. 19.

    Varela, I. et al. Nature 469, 539–542 (2011).

    CAS  Article  Google Scholar 

  20. 20.

    Jones, et al. Curr. Protoc. Bioinforma. 56, 15.10.1–15.10.18 (2016).

    Article  Google Scholar 

  21. 21.

    Van Loo, et al. Proc. Natl Acad. Sci. 107, 16910–16915 (2010).

    CAS  Article  Google Scholar 

Download references


This work was supported by The Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001202), the UK Medical Research Council (FC001202) and the Wellcome Trust (FC001202) (M.T. and P.V.L.). M.T. is supported as a postdoctoral fellow by the European Union’s Horizon 2020 research and innovation program (Marie Skłodowska-Curie Grant agreement no. 747852-SIOMICS). P.V.L. is a Winton Group Leader in recognition of the Winton Charitable Foundation’s support toward the establishment of The Francis Crick Institute. I.M. is funded by a Cancer Research UK Career Development Fellowship (C57387/A21777). D.C.W. is funded by the Li Ka Shing Foundation. This work was supported by grant 1U24CA210957 to P.T.S.. F.M. acknowledges support from the University of Cambridge, Cancer Research UK and Hutchison Whampoa Limited. Parts of this work were funded by Cancer Research UK core grant C14303/A17197 (F.M.). This project was enabled through access to the MRC eMedLab Medical Bioinformatics infrastructure, supported by the UK Medical Research Council (grant no. MR/L016311/1) (M.T. and P.V.L.). Parts of the results published here are based on data generated by the TCGA Research Network (

Author information





M.T., I.M., M.G., A.M.L., F.M., P.T.S., Q.D.M., O.C.L., D.C.W. and P.V.L. participated in argumentation. M.T., O.C.L., D.C.W. and P.V.L. derived the deterministic equations. M.T. wrote the code and generated the figures, with input from I.M., M.G., O.C.L., D.C.W. and P.V.L.; M.T., O.C.L., D.C.W. and P.V.L. drafted the manuscript, which was revised by I.M., M.G., A.M.L., F.M., P.T.S. and Q.D.M. All authors read and approved the manuscript.

Corresponding author

Correspondence to Peter Van Loo.

Supplementary information

Supplementary Text and Figures

Supplementary Note and Supplementary Figures 1–3

Reporting Summary

Supplementary Software

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Tarabichi, M., Martincorena, I., Gerstung, M. et al. Neutral tumor evolution?. Nat Genet 50, 1630–1633 (2018).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing